Healthcare / Medical Care FacilitiesSão Paulo
$1.23
-0.11 (-8.21%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 13%
FCF escenarios
weak_data · normalized FCF $-363.3M · quality 34.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
8/100
F
Piotroski
2/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$1.4B
P/E
N/A
•EV/EBITDA
N/A
•ROE
-402.2%
↓Gross Margin
31.1%
↓Debt/Equity
4.22
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+12.0%
FCF CAGR
—
FCF margin
-5.0%
FCF / Net income
0.08x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $5.74B · net income $-3.62B · FCF $-286.7M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $5.74B | $5.74B | $6.23B | $5.49B | $4.09B |
| Net Income | $-3.62B | $-3.62B | $-646.2M | $223.6M | $46.3M |
| EBITDA | $-2.23B | $-2.23B | $271.2M | $1.12B | $693.2M |
| EPS | -4.18 | -4.18 | -1.05 | 0.42 | 0.08 |
| Gross Margin | 31.1% | 31.1% | 33.1% | 35.1% | 35.5% |
| Operating Margin | -43.0% | -43.0% | -2.3% | 13.5% | 10.9% |
| Net Margin | -63.1% | -63.1% | -10.4% | 4.1% | 1.1% |
| Balance Sheet | |||||
| Debt/Equity | 4.22 | 4.22 | 1.74 | 1.98 | 1.64 |
| Current Ratio | 0.46 | 0.46 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-286.7M | $-286.7M | $-399.1M | $-363.3M | $-571.8M |
| Returns | |||||
| ROE | -402.2% | -402.2% | -20.5% | 9.7% | 2.2% |
| Valuation | |||||
| P/E | — | — | — | 29.77 | 70.21 |
| EV/EBITDA | — | — | 23.71 | 9.52 | 9.32 |
| P/B | 1.18 | 1.18 | 0.48 | 2.89 | 1.53 |
| Growth & Yield | |||||
| Revenue Growth | -7.8% | -7.8% | 13.5% | 34.3% | — |
| EPS Growth | -298.9% | -298.9% | -351.1% | 398.8% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-75.4%
Start / end P/E
n/dx → n/dx
EPS bridge
-1.05 → -4.18
Residual
-75.4%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.